Biosyent Valuation
| RX Stock | CAD 11.26 0.08 0.71% |
At this time, the firm appears to be overvalued. Biosyent shows a prevailing Real Value of C$9.39 per share. The current price of the firm is C$11.26. Our model approximates the value of Biosyent from analyzing the firm fundamentals such as Profit Margin of 0.21 %, current valuation of 114.57 M, and Return On Equity of 0.21 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Biosyent's valuation include:
Price Book 3.4957 | Enterprise Value 114.6 M | Enterprise Value Ebitda 11.5459 | Price Sales 3.9009 | Forward PE 14.0845 |
Overvalued
Today
Please note that Biosyent's price fluctuation is not too volatile at this time. Calculation of the real value of Biosyent is based on 3 months time horizon. Increasing Biosyent's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Biosyent stock is determined by what a typical buyer is willing to pay for full or partial control of Biosyent. Since Biosyent is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biosyent Stock. However, Biosyent's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.26 | Real 9.39 | Hype 11.26 | Naive 11.53 |
The intrinsic value of Biosyent's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biosyent's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biosyent helps investors to forecast how Biosyent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biosyent more accurately as focusing exclusively on Biosyent's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Biosyent's intrinsic value based on its ongoing forecasts of Biosyent's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Biosyent's closest peers.
Biosyent Cash |
|
Biosyent Valuation Trend
Analysing the historical paterns of Biosyent's enterprise value and its market capitalization is a good way to estimate and gauge the value of Biosyent over time and is usually enough for investors to make rational market timing decisions.
Biosyent Total Value Analysis
Biosyent is at this time estimated to have valuation of 114.57 M with market capitalization of 131.94 M, debt of 1.22 M, and cash on hands of 22.46 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Biosyent fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
114.57 M | 131.94 M | 1.22 M | 22.46 M |
Biosyent Investor Information
About 34.0% of the company outstanding shares are owned by corporate insiders. The book value of Biosyent was at this time reported as 2.96. The company last dividend was issued on the 4th of September 2024. Based on the key indicators related to Biosyent's liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, Biosyent is performing exceptionally good at this time. It has a great probability to report excellent financial results in January.Biosyent Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biosyent has an asset utilization ratio of 76.07 percent. This indicates that the Company is making C$0.76 for each dollar of assets. An increasing asset utilization means that Biosyent is more efficient with each dollar of assets it utilizes for everyday operations.Biosyent Ownership Allocation
The market capitalization of Biosyent is C$131.94 Million. Biosyent retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Biosyent Profitability Analysis
The company reported the previous year's revenue of 31.59 M. Net Income was 6.46 M with profit before overhead, payroll, taxes, and interest of 22.86 M.About Biosyent Valuation
Our relative valuation model uses a comparative analysis of Biosyent. We calculate exposure to Biosyent's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biosyent's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 25.1 M | 26.4 M | |
| Pretax Profit Margin | 0.27 | 0.28 | |
| Operating Profit Margin | 0.24 | 0.25 | |
| Net Profit Margin | 0.20 | 0.21 | |
| Gross Profit Margin | 0.81 | 0.56 |
Additional Tools for Biosyent Stock Analysis
When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.